As of 2026-01-02, the Intrinsic Value of 89Bio Inc (ETNB) is -15.16 USD. This 89Bio valuation is based on the model Peter Lynch Fair Value. With the current market price of 14.84 USD, the upside of 89Bio Inc is -202.15%.
Based on its market price of 14.84 USD and our intrinsic valuation, 89Bio Inc (ETNB) is overvalued by 202.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.16 - -15.16 | -15.16 | -202.15% |
| P/E | (23.28) - (44.21) | (32.52) | -319.1% |
| DDM - Stable | (23.73) - (78.56) | (51.15) | -444.7% |
| DDM - Multi | (0.55) - (1.38) | (0.78) | -105.3% |
| Market Cap (mil) | 2,203.59 |
| Beta | 1.71 |
| Outstanding shares (mil) | 148.49 |
| Enterprise Value (mil) | 2,110.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.21% |
| Cost of Debt | 5.00% |
| WACC | 10.12% |